SOPHiA GENETICS SA (SOPH) Insider Trading -- Recent Executive & Director Transactions
14 insiders reported 178 Form 4 transactions for SOPHiA GENETICS SA (SOPH) over the past 18 months (most recent 2026-10-07). Recent activity: CARDOZA GEORGE (Chief Financial Officer) Sell 1,592 shares, Muken Ross (Chief Executive Officer) Sell 9,838 shares, Xu Zhenyu (Chief Scientific Officer) Sell 7,394 shares, Van Well Daan (Chief Legal Officer) Sell 6,168 shares, Camblong Jurgi (Executive Chairman) Sell 40,172 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-07 | CARDOZA GEORGE | Chief Financial Officer | Sell | 1,592 | $12,897 |
| 2026-10-07 | Muken Ross | Chief Executive Officer | Sell | 9,838 | $79,971 |
| 2026-10-07 | Xu Zhenyu | Chief Scientific Officer | Sell | 7,394 | $60,075 |
| 2026-10-07 | Van Well Daan | Chief Legal Officer | Sell | 6,168 | $50,100 |
| 2026-10-07 | Camblong Jurgi | Executive Chairman | Sell | 40,172 | $326,526 |
| 2026-10-07 | Valente Manuela | Chief People Officer | Sell | 4,240 | $34,487 |
| 2026-10-07 | Menu Philippe | Chief Medical Officer | Sell | 7,394 | $60,100 |
| 2026-10-07 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,284 | $42,929 |
| 2026-10-07 | Puylaert Kevin | Chief Sales Officer | Sell | 185 | $1,491 |
| 2026-10-07 | Puylaert Kevin | Chief Sales Officer | Sell | 31 | $246 |
| 2026-09-22 | CARDOZA GEORGE | Chief Financial Officer | Sell | 774 | $6,447 |
| 2026-09-22 | Muken Ross | Chief Executive Officer | Sell | 422 | $3,515 |
| 2026-09-16 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,000 | $31,538 |
| 2026-09-16 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | $39,416 |
| 2026-09-14 | Van Well Daan | Chief Legal Officer | Sell | 6,168 | $47,089 |
| 2026-09-14 | Camblong Jurgi | Executive Chairman | Sell | 8,500 | $65,120 |
| 2026-09-10 | HIBBS KATHY L | Director | Sell | 6,250 | $50,818 |
| 2026-08-31 | Xu Zhenyu | Chief Scientific Officer | Sell | 10,000 | $89,096 |
| 2026-08-26 | HIBBS KATHY L | Director | Sell | 6,250 | $54,233 |
| 2026-08-26 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | $43,396 |
| 2026-08-26 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,000 | $41,000 |
| 2026-08-26 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,000 | $44,000 |
| 2026-08-21 | Xu Zhenyu | Chief Scientific Officer | Sell | 10,000 | $79,427 |
| 2026-08-21 | Valente Manuela | Chief People Officer | Buy | 10,000 | $32,000 |
| 2026-08-21 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,592 | $38,609 |
Source: SEC Form 4 filings · as of 2026-10-07